The Data and Safety Monitoring Board has notified the drugmaker, NIAID and the Biomedical Advanced Research and Development Authority regar...

Collins estimates that the FDA would need about three weeks to analyze the trial data, after which an expert advisory panel will meet and v...

The AstraZeneca vaccine is already being administered in Brazil, but is registered only for emergency use, and the doses have been imported...

The data indicates that the vaccine will not need to be modified in order to protect against the variant, which is believed to have origina...

AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vac...

The AstraZeneca vaccine costs a fraction of the price set by Pfizer and will be manufactured in multiple countries, from India to Brazil. I...

The drugmaker called the results from the study disappointing but said it remained committed to its clinical trials for its COVID-19 vaccin...

A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people,...

Most vaccines in human testing require two shots for effectiveness, and developers still aren’t even sure if they’ll prevent infections. Sc...

Serum Institute, the world's largest vaccine maker by the number of doses produced, will develop Codagenix's CDX-005, which is delivered in...

The Serum Institute of India said it would restart its trials once it had permission from the Drugs Controller General of India, Reuters re...

AstraZeneca Plc said it had paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unex...

The pan-European STOXX 600 index rose 0.8%, with sub-indexes of sectors hit most by the pandemic lagging. Travel and leisure stocks fell 1....

AstraZeneca began its Phase 3 trial in the US in late August. The US trial was currently taking place at 62 sites across the country.

The deal underscores Astra's frontrunner position in a global race to deliver an effective vaccine, given that Chinese ventures are leading...

Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune r...

AstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc. about a potential merger.